BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23161122)

  • 1. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
    Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
    Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
    Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
    Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
    Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
    Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
    Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
    Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric Placement.
    Brualla L; Zaragoza FJ; Sauerwein W
    Ocul Oncol Pathol; 2014 Oct; 1(1):2-12. PubMed ID: 27175356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
    Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
    Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL; Leonard KL; Rivard MJ
    Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo Simulation of the Treatment of Uveal Melanoma Using Measured Heterogeneous
    Zaragoza FJ; Eichmann M; Flühs D; Wittig A; Sauerwein W; Brualla L
    Ocul Oncol Pathol; 2019 Jun; 5(4):276-283. PubMed ID: 31367591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
    Kamrani S; Aghamiri SMR; Hashemi S
    Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
    Mourtada F; Koch N; Newhauser W
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):454-60. PubMed ID: 16604677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.